Cost-effectiveness of measles outbreak intervention strategies

Australian and New Zealand Journal of Public Health

Volumn 22, Issue 1, 1998, Pages 126-132

  Shiell, Alan ^a   Jorm, Louisa R ^b   Carruthers, Robert ^a   Fitzsimmons, Gerard J ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b New South Wales Government   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE;

ARTICLE; CHILD; COST EFFECTIVENESS ANALYSIS; DISEASE CONTROL; ECONOMIC EVALUATION; FEMALE; HUMAN; HUMAN EXPERIMENT; INFANT; MALE; MEASLES; MEASLES VACCINATION; NORMAL HUMAN; SIBLING;

EID: 0031803144     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-842x.1998.tb01156.x     Document Type: Article

References (44)

1. Clements CJ, Strassburg M, Cutts FT, Torel C. The epidemiology of measles. World Health Stat Q 1992; 45: 285-91.
2. Cliff A, Haggett P, Smallman-Raynor M. Measles: an historical geography of a major human viral disease from global expansion to local retreat. 1840-1990. Oxford. Blackwell, 1993.
3. Hawe P. Measles control: a best-practice challenge in public health. Aust J Public Health 1994; 18: 241-3.
4. Gustafason TL, Lievens AW, Brunell PA, Moellenberg RG, et al. Measles outbreak in a fully immunized secondary-school population. N Engl J Med 1987; 316: 771-4.
5. Herceg A, Passaris I, Mead C. An outbreak of measles in a highly immunised population: immunisation status and vaccine efficacy Aust J Public Health 1994; 18: 249-52.
6. Miles T, Merrell WH. An outbreak of measles in the Hunter area of New South Wales. Aust J Public Health 1992; 16: 302-4.
7. Albritton RB. Cost-benefits of measles eradication: effects of a federal intervention. Policy Anal 1975; 4: 1-22.
8. Koplan JP, White CC. An update on the benefits and costs of measles and rubella immunization. In: Gruenberg EM, Lewis C, Goldston S, editors. Immunizing against mental disorders: progress in the conquest of measles and rubella. Oxford: Oxford University Press, 1985.
9. White CC, Koplan JP, Orenstein WA. Benefits, risks and costs of immunization for measles, mumps and rubella. Am J Public Health 1985; 75: 739-44.
10. Ginsberg G, Tulchinsky TH. Costs and benefits of a second measles inoculation of children in Israel, the West Bank and Gaza. J Epidemiol Community Health 1990; 44: 274-80.
11. Tulchinsky TH, Ginsberg GM, Abed Y, Angeles MT, et al. Measles control in developing and developed countries: the case for a two-dose policy. Bull World Health Organ 1993; 71: 93-103.
12. Watson JC, Pearson JA, Markowitz LE, Baughman AL, et al. An evaluation of measles revaccination among school-entry-aged children. Pediatrics 1996; 97: 613-18.
13. Infectious diseases manual. 4th edn. Sydney: AIDS/Infectious Diseases Branch, NSW Health Department, 1995.
14. National Health and Medical Research Council. Measles: guidelines for the control of outbreaks in Australia. Canberra: Australian Government Publishing Service, 1996.
15. Davis RM, Markowitz LE, Preblud SR, Orenstein WA, Hinman AR. A cost-effectiveness analysis of measles outbreak control strategies. Am J Epidemiol 1987; 126: 450-9.
16. Hutchins SS, Markowitz LE, Mead P, Mixon D, et al. A school-based measles outbreak: the effect of a selective revaccination policy and risk factors for vaccine failure. Am J Epidemiol 1990; 132: 157-68.
17. Mast EE, Berg JL, Hanrahan LP, Wassell JT, Davis JP. Risk factors for measles in a previously vaccinated population and cost-effectiveness of revaccination strategies. JAMA 1990; 264: 2529-33.
18. Robertson SE, Markowitz LE, Berry DA, Dini EF, Orenstein WA. A million dollar measles outbreak: epidemiology, risk factors and a selective revaccination strategy. Public Health Rep 1992; 107: 24-31.
19. Kakakios AM, Burgess MA, Bransby RD, Quinn AA, Allars HM. Optimal age for measles and mumps vaccination in Australia. Med J Aust 1990; 152: 472-4.
20. McDonnell LF, Jorm LR, Patel MS. Measles outbreak in western Sydney: vaccine failure or failure to vaccinate? Med J Aust 1995; 162: 471-5.
21. McDonnell LF, Jorm LR. Measles epidemic in western Sydney. NSW Public Health Bull [NSW Health Department] 1994; 5: 59-60.
22. McNeil BJ, Pauker SG. Decision analysis for public health: principles and illustrations. Annu Rev Public Health 1984; 5: 135-61.
23. 1989-90 national health survey: user's guide. Cat. no. 4360.0. Canberra: Australian Bureau of Statistics, 1991.
24. Bazeley P. Public and private immunisation services: a comparison of costs. Community Health Stud 1989; XIII: 336-40.
25. Cheah D. An estimate of measles vaccine efficacy in a Canberra primary school. Commun Dis Intell 1992; 16: 294-6.
26. McCormick JB, Halsey N, Rosenberg R. Measles vaccine efficacy determined from secondary attack rates during a severe epidemic. J Pediatr 1977; 90: 13-16.
27. 1991 census of population and housing (special tabulation). Canberra: Australian Bureau of Statistics, 1995.
28. Lennon JL, Black F. Maternally derived measles immunity in era of vaccine protected mothers. J Pediatr 1986; 108: 671-6.
29. Drummond MF, Stoddart GL, Toriance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press, 1987.
30. Slaytor MA, James OF, Moore PG, Leeder SR. Costs, severity of illness and outcomes in intensive care. Anaesth Intensive Care 1986; 20: 165-79 .
31. Briggs A, Sculpher M, Buxton M. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Eton 1994; 3: 95-104.
32. Scott A, Shiell A, Farnworth M. The value of early discharge: dispelling some myths. Health Policy 1993; 26: 81-91.
33. Measles surveillance report no. 11, 1977-1981. Atlanta: Centers for Disease Control, 1982.
34. Anderson RM, May RM. Infectious diseases of humans: dynamics and control. Oxford: Oxford University Press, 1991.
35. Shlian DM, Matchar D, Seymann GB. Cost-effectiveness of measles immunization strategies on a college campus. Fam Pract Res J 1991; 11: 193-207.
36. Alberman E, Watson E, Mitchell P, Day S. The development of performance and cost indicators for preschool immunisation. Arch Dis Child 1986; 61: 251-6.
37. Ferson MJ, Christie D. Measles immunisation compliance: poor impact of bicentennial measles control campaigns on children under five. Aust J Public Health 1992; 16: 31-4.
38. Bell JC, Whitehead P, Chey T, Smith W, et al. The epidemiology of incomplete childhood immunization: an analysis of reported immunization status in outer western Sydney. J Paediatr Child Health 1993; 29: 384-8.
39. De Silva LM, Karlekar AV. Measles susceptibility under one year of age and vaccination strategy. Med J Aust 1994; 161: 725.
40. Ferson MJ, Whybin LR, Robertson PW. Pilot study of measles immunity in infants aged four to six months. Commun Dis Intell 1995; 19: 30-1.
41. Serres G, Boulianne N, Ratnam S, Corriveau A. Effectiveness of vaccination at 6 to 11 months of age during an outbreak of measles. Pediatrics 1996; 97: 232-5.
42. Dagan R, Slater PE, Duvdevani P, Golubev N, Mendelson E. Decay of maternally derived measles antibody in a highly vaccinated population in southern Israel. Paediair Infect Dis J 1995; 14: 965-9.
43. National Health and Medical Research Council. The Australian immunisation procedures handbook. 5th edn. Canberra: Australian Government Publishing Service, 1994.
44. Fine PE, Zell ER. Outbreaks in highly vaccinated populations: implications for studies of vaccine performance. Am J Epidemiol 1994; 139: 77-90.